Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Mangoceuticals Inc
MGRX
Technology
Health Information Services
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also...
provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:MGRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(40)
•••
Bullhunk
X
Post by
Bullhunk
on Mar 23, 2026 10:25am
time to get some
looks like this is the one for big things to happen.
(165)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Nov 13, 2025 8:57am
Buy buddy buy.
Otherwise FOMO for you fellas out there today anyway,so good luck to all of you guys
Atlas Salt Announces $1.25 Million Flow-Through Financing
posted May 20, 2026 9:00am by
Atlas Salt Inc.
-
|
The gross proceeds to incur eligible "Canadian exploration expenses" that will qualify as "flow-through mining expenditures" as such terms are defined in the Tax Act to advance exploration on the nepheline discovery at its Black Bay Property in Southern Labrador ...read more
(10)
•••
MikeTester
X
Post by
MikeTester
on Jan 24, 2025 2:17am
Mangoceuticals, Inc. (MGRX): A Diversified Player in the Men
Interesting play in men's health market. MGRX looks like a speculative bet with some potential. Revenues are tiny at $510k for 9 months in 2024 but they've got multiple product lines targeting
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 31, 2024 8:00am
New Press Release - Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Dallas, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, today announced that the Company received a letter on...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 22, 2024 8:00am
New Press Release - MangoRx Announces Formation of Strategy and Alternatives Committee
Dallas, Texas, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, today announced that its Board of Directors has...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 21, 2024 5:10pm
New Press Release - MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform learned earlier this morning that Eli Lilly has made...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 18, 2024 8:46am
New Press Release - Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024
Dallas, Texas--(Newsfile Corp. - October 18, 2024) - Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform,, is pleased to announce it will be presenting at the Centurion One Capital 2nd...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 11, 2024 5:15pm
New Press Release - MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
DALLAS, TX, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, weight loss, and hormone...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 03, 2024 8:30am
New Press Release - MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, announces the release of its latest innovation, “TRIM,”...
read article.
(1491)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 2:33pm
MGRX.....let's cut to the chase.....hurry up with the
P.O announcement Waiting patiently ; )
(1491)
•••
Iseneschal
X
Comment by
Iseneschal
on Oct 01, 2024 12:32pm
RE:MGRX....will this turn into a Gree to Red move
Green*......sheesh
(1491)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 12:31pm
MGRX....will this turn into a Gree to Red move
lots of resistance above and to 40 cents....next support is 20 cents Just my 2bits
(1491)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 11:52am
MGRX.....Well how do you like me so far?????
Re-read my last post Cheers !
(1491)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 8:24am
MGRX....Early a.m runner...but there is a reason ; )
Here is the fluff NR this a.m.....make sure you read my whole post ; ) MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
...more
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 12:03pm
Mangoceuticals, Inc. (MGRX): Navigating the Evolving MenR
https://beyondspx.com/2024/07/31/mangoceuticals-inc-mgrx-navigating-the-evolving-mens-wellness-landscape/
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Walkthrough one of the most strategic and technologically advanced Tungsten mines in the world
Western Star Consolidates the Past Producing Jarbidge-Charleston Tungsten Complex in Elko, Nevada
Podcasts